| Single delivery of high-diversity fecal microbiota preparation by colonoscopy is safe and effective in increasing microbial diversity in active ulcerative colitis V Jacob, C Crawford, S Cohen-Mekelburg, M Viladomiu, GG Putzel, ... Inflammatory bowel diseases 23 (6), 903-911, 2017 | 114 | 2017 |
| Lymphocytic esophagitis: a diagnosis of increasing frequency S Cohen, A Saxena, AK Waljee, C Piraka, J Purdy, H Appelman, ... Journal of clinical gastroenterology 46 (10), 828-832, 2012 | 82 | 2012 |
| Tofacitinib for biologic-experienced hospitalized patients with acute severe ulcerative colitis: a retrospective case-control study JA Berinstein, JL Sheehan, M Dias, EM Berinstein, CA Steiner, ... Clinical Gastroenterology and Hepatology 19 (10), 2112-2120. e1, 2021 | 80 | 2021 |
| Development and validation of machine learning models in prediction of remission in patients with moderate to severe Crohn disease AK Waljee, BI Wallace, S Cohen-Mekelburg, Y Liu, B Liu, K Sauder, ... JAMA network open 2 (5), e193721-e193721, 2019 | 70 | 2019 |
| Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer … AK Waljee, PDR Higgins, CB Jensen, M Villumsen, SA Cohen-Mekelburg, ... The Lancet Gastroenterology & Hepatology 5 (3), 276-284, 2020 | 55 | 2020 |
| Fragmented care is prevalent among inflammatory bowel disease readmissions and is associated with worse outcomes S Cohen-Mekelburg, R Rosenblatt, S Gold, N Shen, B Fortune, AK Waljee, ... Official journal of the American College of Gastroenterology| ACG 114 (2 …, 2019 | 41 | 2019 |
| The impact of opioid epidemic trends on hospitalised inflammatory bowel disease patients S Cohen-Mekelburg, R Rosenblatt, S Gold, R Burakoff, AK Waljee, ... Journal of Crohn's and Colitis 12 (9), 1030-1035, 2018 | 40 | 2018 |
| The North American Consortium for the Study of End‐Stage Liver Disease–Acute‐on‐Chronic Liver Failure Score accurately predicts survival: an external validation using a … R Rosenblatt, N Shen, Z Tafesh, S Cohen‐Mekelburg, CV Crawford, ... Liver Transplantation 26 (2), 187-195, 2020 | 32* | 2020 |
| Incidence and predictors of new persistent opioid use following inflammatory bowel disease flares treated with oral corticosteroids M Noureldin, PDR Higgins, SM Govani, S Cohen‐Mekelburg, BC Kenney, ... Alimentary pharmacology & therapeutics 49 (1), 74-83, 2019 | 31 | 2019 |
| Testing and treating small intestinal bacterial overgrowth reduces symptoms in patients with inflammatory bowel disease S Cohen-Mekelburg, Z Tafesh, E Coburn, R Weg, N Malik, C Webb, ... Digestive diseases and sciences 63, 2439-2444, 2018 | 30 | 2018 |
| Perianal fistulas in patients with Crohn’s disease, part 1: current medical management SL Gold, S Cohen-Mekelburg, Y Schneider, A Steinlauf Gastroenterology & Hepatology 14 (8), 470, 2018 | 29 | 2018 |
| Early paracentesis in high-risk hospitalized patients: time for a new quality indicator R Rosenblatt, Z Tafesh, N Shen, S Cohen-Mekelburg, S Kumar, C Lucero, ... Official journal of the American College of Gastroenterology| ACG 114 (12 …, 2019 | 24 | 2019 |
| Disability in inflammatory bowel disease patients is associated with race, ethnicity and socio‐economic factors M Agrawal, S Cohen‐Mekelburg, M Kayal, J Axelrad, J Galati, B Tricomi, ... Alimentary pharmacology & therapeutics 49 (5), 564-571, 2019 | 22 | 2019 |
| Perianal fistulas in patients with Crohn’s disease, Part 2: Surgical, endoscopic, and future therapies SL Gold, S Cohen-Mekelburg, Y Schneider, A Steinlauf Gastroenterology & hepatology 14 (9), 521, 2018 | 19 | 2018 |
| Evaluation of narrow-band imaging signs in eosinophilic and lymphocytic esophagitis T Ichiya, K Tanaka, CA Rubio, U Hammar, PT Schmidt Endoscopy 49 (05), 429-437, 2017 | 18 | 2017 |
| Coordination of care is associated with survival and health care utilization in a population-based study of patients with cirrhosis S Cohen-Mekelburg, AK Waljee, BC Kenney, EB Tapper Clinical Gastroenterology and Hepatology 18 (10), 2340-2348. e3, 2020 | 17 | 2020 |
| Cirrhosis as a comorbidity in conditions subject to the hospital readmissions reduction program R Rosenblatt, S Cohen-Mekelburg, N Shen, Z Tafesh, C Lucero, S Kumar, ... Official journal of the American College of Gastroenterology| ACG 114 (9 …, 2019 | 16 | 2019 |
| Premedication use in preventing acute infliximab infusion reactions in patients with inflammatory bowel disease: a single center cohort study SL Gold, S Cohen-Mekelburg, Y Schneider, N Shen, A Faggen, A Rupert, ... Inflammatory Bowel Diseases 23 (10), 1882-1889, 2017 | 15 | 2017 |
| Trends of 5-aminosalicylate medication use in patients with Crohn disease M Noureldin, S Cohen-Mekelburg, A Mahmood, R Stidham, PDR Higgins, ... Inflammatory bowel diseases 27 (4), 516-521, 2021 | 14 | 2021 |
| The association of medications and vaccination with risk of pneumonia in inflammatory bowel disease MH Gregory, MA Ciorba, WL Wiitala, RW Stidham, P Higgins, SC Morley, ... Inflammatory bowel diseases 26 (6), 919-925, 2020 | 14 | 2020 |
Akbar K. WaljeeProfessor, University of MichiganEmail verificata su umich.edu
